Tonix is developing innovative pharmaceutical products to address major public health challenges. In addition to Tonmya for PTSD, Tonix is developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (Investigational New Drug) application stage, designed as a daytime treatment for PTSD, and TNX-801, a live synthetic version of horsepox virus, at the pre-IND application stage, to be developed as a potential smallpox-preventing vaccine.

Pharmaceutical

Tonix Pharmaceuticals

Seth Lederman

Stephanie Valdez Trefry

Ram Patalapati

Jean Engels

Scott Szymanski

Anthony MacAluso

Sina Bavari

Darryl Rideout

Bradley Saenger

Jessica Edgar Morris

Gregory Sullivan

Siobhan Fogarty

Tonix Pharmaceuticals' Founding Team includes Seth Lederman.

Founding Team

Board of Directors

CEO and Executive Team

Leadership Team

Founding Team

About

Team members

Other teams at Tonix Pharmaceuticals

Board of Directors

CEO and Executive Team

Leadership Team